IRSF investment positions organization at the forefront of early-stage Rett research as genomic medicine reshapes rare ...
The transition from non-life to life was very likely aided by an asteroid hitting Earth, prebiotic chemistry, molecular ...
Immuto CEO Faraz Choudhury spoke with Pharmaceutical Executive about his company’s work with focusing on Surface Protein Conformations (SPCs) for target discovery. According to him, traditional target ...
FDA's Plausible Mechanism Framework streamlines individualized therapy approvals for ultra-rare diseases.
Human MAP1LC3B (LC3B) binds proteins involved in autophagy and other cellular processes using a degenerate four-residue short linear motif known as the LC3-interacting region (LIR). Biochemical and ...
A pore smaller than one nanometer reads peptide sequences amino acid by amino acid, pinpointing single-site Alzheimer's ...
Mr. Beast, or Jimmy Donaldson, has revealed that he is borderline blind. Here is what it means and the early signs of the ...
Q4 2025 Earnings Call February 26, 2026 4:30 PM ESTCompany ParticipantsMike Brophy - Chief Financial OfficerSteve Chapman - CEO ...
Researchers summarize key insights from the world’s first comprehensive investigation into how a pandemic started.
In the wake of the germline editing controversy, when Chinese scientist He Jianku illegally edited the embryos of human twins ...
Rare diseases often hide in plain sight — behind delayed milestones, feeding difficulties or symptoms that seem minor at first glance. Lesch-Nyhan Syndrome (LNS ...
The bispecific ADC izalontamab brengitecan improved survival for patients with metastatic triple-negative breast cancer in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results